2025 Family Conference: Secondary Prevention Update (Spanish)

Description: An update on recent developments in DIAN secondary prevention research, including discussion of trials investigating the possibility of delaying the onset of Alzheimer’s disease symptoms, and funding of ongoing DIAN research
Runtime: 00:25:23

Speaker: Randall Bateman, MD
Speaker title: DIAN Trials Unit Director; DIAN Observational Study Co-Director
Speaker organization: Washington University in St. Louis

Event: 2025 DIAD Family Conference: Dedicated to Impact
Location: Toronto, Ontario, Canada
Year: 2025

Search tags: DIAN history, gantenerumab, anti-amyloid immunotherapy, open-label extension, DIAN-TU-001 Trial, research participation, preclinical Alzheimer’s, delayed onset, CSF, cerebrospinal fluid, biomarkers, lecanemab, DIAN-TU-003 Trial, Amyloid Removal Trial, DIAN-TU NexGen Trial, antisense oligonucleotide, research funding